Glymark-M1 — Glimepiride 1 mg + Metformin 500 mg (SR) pack shot by MARKHZ Biosciences
Anti-Diabetic

Glymark-M1

Glimepiride 1 mg + Metformin 500 mg (SR)

Glymark-M1 is a fixed-dose combination of Glimepiride 1 mg and Metformin 500 mg in a sustained-release formulation. It supports better blood sugar control in adults with Type 2 Diabetes Mellitus inadequately managed by diet, exercise or single-agent therapy.

Pack
10 x 10 Tablets
Category
Anti-Diabetic
Enquire about Glymark-M1

Indications / Common Uses

  • Type 2 Diabetes Mellitus in adults
  • Patients requiring dual oral anti-diabetic therapy
  • Inadequate glycemic control on Metformin monotherapy

Benefits

  • Improves fasting and post-prandial blood glucose
  • Sustained-release action for smoother control
  • Reduces HbA1c with balanced insulin response

Dosage Information

One tablet once or twice daily with meals, as prescribed by a diabetologist or registered medical practitioner.

General information only. Follow your physician's prescription.

Storage

Store below 30°C in a dry place. Protect from light and moisture. Keep out of reach of children.

Precautions

  • Regular monitoring of blood glucose and renal function is advised
  • Not recommended in severe renal or hepatic impairment
  • Avoid alcohol consumption during therapy

Medical Disclaimer

The information provided is for general awareness only and is not a substitute for professional medical advice, diagnosis or treatment. Always seek the guidance of a qualified physician regarding any medical condition or medication.

Related Products

Glymark-M2 — Glimepiride 2 mg + Metformin 500 mg (SR) pack shot
Anti-Diabetic

Glymark-M2

Glimepiride 2 mg + Metformin 500 mg (SR)

Higher-strength sustained-release Glimepiride and Metformin combination for advanced Type 2 Diabetes management.

10 x 10 TabletsKnow More
MARKVIL-M — Vildagliptin 50 mg + Metformin HCl 500 mg pack shot
Anti-Diabetic

MARKVIL-M

Vildagliptin 50 mg + Metformin HCl 500 mg

A DPP-4 inhibitor plus Metformin combination for comprehensive Type 2 Diabetes management.

10 x 10 TabletsKnow More
MARST-BL — Bilastine 20 mg + Montelukast 10 mg pack shot
Anti-Allergic

MARST-BL

Bilastine 20 mg + Montelukast 10 mg

A dual-action anti-allergic tablet combining Bilastine and Montelukast for effective relief from allergic rhinitis and related symptoms.

10 x 10 TabletsKnow More
Call nowWhatsApp